Indian Emulsifiers Limited: FY26 Growth at Scale, With Working Capital and Margin Trade-offs

Indian Emulsifiers Limited closed FY26 with a sharp step-up in scale. Consolidated total income rose to 160.19 crore from 102.66 crore in FY25, a 56.0 percent year-on-year increase. EBITDA increased to 26.22 crore from 21.05 crore, and profit after tax rose to 16.26 crore from 13.30 crore. The company attributed the performance to market expansion and deeper customer engagement, while acknowledging that margins moderated as it prioritized volume-led growth.

The year also showed the typical side-effects of rapid scaling in a specialty chemicals business: higher working capital, rising receivables, and a deliberate inventory build to manage supply risks. Management commentary emphasized that despite these shifts, the cash conversion cycle remained broadly stable because creditor days improved with higher procurement volumes and stronger supplier relationships.

FY26 performance: revenue acceleration, margin compression

The consolidated income statement shows strong top-line momentum across both halves of the year. H2FY26 total income came in at 82.96 crore versus 50.00 crore in H2FY25, reflecting growth of 65.9 percent. However, profitability did not rise in the same proportion. H2FY26 EBITDA increased to 10.88 crore from 9.65 crore, but H2FY26 PAT declined to 5.99 crore from 6.32 crore and EPS fell to 3.99 from 5.43.

At the full-year level, EBITDA margin reduced to 16.37 percent in FY26 from 20.50 percent in FY25. PAT margin also reduced to 10.15 percent from 12.96 percent. Management positioned this as a deliberate trade-off, focusing on volume growth and geographic expansion, with an expectation that procurement efficiencies and stronger supplier relationships would support margin improvement over time.

Working capital: higher receivables and inventories to support growth

Management commentary highlighted a clear rise in working capital deployment, which increased to 50.73 crore from 36.31 crore. A key driver was receivables, as debtor days increased from approximately 110 days to 131 days. The stated reason was expansion into larger customers and markets where longer credit cycles are standard.

The balance sheet reflects this shift. Trade receivables increased to 57.34 crore in FY26 from 30.61 crore in FY25. Inventory also rose to 64.45 crore from 36.41 crore. Management said inventory was strategically built due to Middle East supply disruptions, raw material price volatility, and anticipated supply constraints. It added that inventory days remained broadly stable on a procurement basis and that, since April 2026, supply conditions have normalized and cost increases have been passed through to customers. Based on this, the company expects inventory efficiency to improve as volumes grow and supply chain processes are optimized.

On the positive side, creditor days improved significantly as procurement volumes increased, which management said helped keep the cash conversion cycle broadly stable despite rapid growth.

Capacity, capability, and geographic expansion: the investment roadmap

Alongside growth in the core specialty chemical portfolio, the presentation outlines a multi-track expansion strategy spanning capacity addition, capability building, and international market access.

A major capex item is the new greenfield manufacturing facility at Plot C-3, Lote Parshuram MIDC, which management said is under construction and expected to be operational by the end of FY27. The company expects this to significantly enhance manufacturing capacity and product capabilities.

Debt levels moved up to support these investments. Long-term borrowings increased to 25.95 crore in FY26 from 6.74 crore in FY25. Management stated this was primarily to fund a new Quality Control and R and D facility, infrastructure for upcoming food grade emulsifier products, and additional equipment.

The presentation also describes specific international initiatives. Southern Emulsifiers, an Australian subsidiary, is positioned as an entry into Australia’s mining explosives emulsifier market. The company stated that the subsidiary is expected to generate approximately 75 crores of revenue over the next three years, with expected margins of 10 to 15 percent and annual improvement of 200 to 300 basis points.

For the U.S., Polaris Specialty Chemicals Inc. is described as a distribution arm that manages customs clearance, localized inventory in tanks and totes, and last-mile delivery to customer sites. Target industries listed include oil and gas, food, water, and textile auxiliaries.

In India, Spartan Professional Products is described as a wholly owned subsidiary representing a move up the value chain into finished formulations. The presentation outlines a dual model of white label manufacturing for third parties and a proprietary own label approach across personal care and cleaning and household categories.

What to watch from here

The FY26 presentation shows a company scaling rapidly, investing into the next leg of growth, and simultaneously managing supply chain volatility. The trade-off is visible in profitability metrics and in a heavier working capital footprint.

Three signposts stand out based on what the company has explicitly disclosed. First is whether margins recover as procurement efficiencies and supplier leverage build with scale. Second is whether receivables normalize after the shift toward larger customers and longer credit cycles. Third is execution on the greenfield facility timeline, which management expects to complete by the end of FY27.

The company also stated it is poised to achieve around 40 to 50 percent revenue CAGR over the next three years, driven by an expanding product portfolio, broader sales channels, and increasing market share. If that growth is achieved alongside tighter working capital discipline and stable margins, FY26 may read as the year Indian Emulsifiers Limited moved from a high-growth phase into a more durable scaling cycle.